Open AccessNifuroxazide Erythema Pigmented Fixed: A Side Effect to Be Aware Off
Author(s) -
Ryme Dassouli*,
Zakia Douhi,
Imane Kacimi,
Kenza Tahiri,
Hanane BayBay,
Sara Elloudi,
Fatima Zahra Mernissi
Publication year - 2022
Language(s) - English
DOI - 10.46889/jdr.2022.3107
Subject(s) - erythema , dermatology , hyperpigmentation , medicine , rash
Erythema Pigmentum Fixata (EPF) is a delayed-type toxidermia. It manifests itself within 48h after the re-introduction of a drug by the appearance of a recurrent rash, leaving a residual hyperpigmentation [1]. We report a first case of erythema pigmentosa fixed to Nifuroxazide.